GlassScriptPhysician profile
Kate Maroney
NPI 1659717924
$2,087.84
in general payments reported to CMS, 2019-2025
25 companies · $392 in 2025
The $392 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $189 · 2021: $29.64 · 2022: $408 · 2023: $323 · 2024: $419 · 2025: $392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,035 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.11 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $252.11 | 2019-2020 | |
| Hologic Sales and Service, LLC | $233.90 | 2020-2025 | Aptima, Myosure Tissue Removal Device, Acessa Provu System |
| Organon LLC | $204.61 | 2021-2025 | Jada System |
| Astellas Pharma US INC | $198.03 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $172.03 | 2022-2024 | |
| Abbvie INC. | $161.69 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $132.72 | 2019-2024 | Gardasil 9, Gardasil |
| Bayer Healthcare Pharmaceuticals INC. | $116.00 | 2019-2025 | |
| Coopersurgical, INC. | $102.56 | 2019-2024 | Paragard T 380a |
| Biogen, INC. | $72.57 | 2024-2025 | Zurzuvae |
| Dexcom, INC. | $70.03 | 2023-2025 | Dexcom G6 Transmitter |
| Baxter Healthcare | $45.76 | 2024 | Perclot |
| Aspira Women'S Health INC | $39.81 | 2024 | Ova1 |
| Teleflex LLC | $38.51 | 2025 | Quikclot |
| Lupin INC. | $36.47 | 2019-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $33.53 | 2019 | |
| Daiichi Sankyo INC. | $28.06 | 2022 | |
| Therapeuticsmd, INC. | $27.72 | 2020 | |
| Gynesonics, INC. | $22.34 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Meditrina | $22.10 | 2025 | |
| Axonics, INC. | $19.21 | 2022 | |
| Pfizer INC. | $16.30 | 2024 | |
| Gilead Sciences, INC. | $14.63 | 2025 | |
| Solventum Corporation | $14.12 | 2025 | |
| Myovant Sciences INC. | $13.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kate Maroney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.